# Parkinson's Pathways

> A free, family-friendly guide to every recruiting Parkinson's disease clinical trial. Currently tracking 566 trials.

## About

Parkinson's Pathways helps patients, caregivers, and clinicians find and understand Parkinson's clinical trials. Every trial is translated for families with a five-word goal, eligibility details, and nearby locations.

Two distinct content tiers are exposed here:

1. **PD Curated** — Parkinson's-only trials with AI-generated family-friendly summaries, five-word goals, geocoded sites, and recent site-change tracking.
2. **Universal Raw Mirror** — A larger, condition-agnostic mirror of ClinicalTrials.gov with no AI summaries and no editorial enrichment. Use this when you need source-of-truth raw data.

Every public page has a clean Markdown twin at `<page-url>.md` with frontmatter, intended for LLM ingestion.

## Key Pages

- [Browse All Trials](https://parkinsonspathways.com/trials): Search and filter all 566 recruiting Parkinson's clinical trials by phase, study type, enrollment size, country, and age eligibility.
- [Trials Near Me](https://parkinsonspathways.com/trials-near-me): Find clinical trials near a specific location using zip code or city search.
- [Insights Dashboard](https://parkinsonspathways.com/insights): Visual overview of the Parkinson's trial landscape, including phase breakdown, intervention types, top sponsors, eligibility stats, and a global map.
- [Learn](https://parkinsonspathways.com/learn): Educational articles explaining clinical trial concepts, translated for families.
- [About](https://parkinsonspathways.com/about): The story behind the project and how it works.

## PD Curated — Learn Articles (Markdown twins)

Each article is available as both HTML (for humans) and Markdown (for LLM ingestion). Markdown URLs include YAML frontmatter with title, description, canonical URL, and publication date.

- Why I Built Parkinson's Pathways — HTML: https://parkinsonspathways.com/learn/why-i-built-parkinsons-pathways — Markdown: https://parkinsonspathways.com/learn/why-i-built-parkinsons-pathways.md
- What Do Clinical Trial Phases Mean? — HTML: https://parkinsonspathways.com/learn/what-do-clinical-trial-phases-mean — Markdown: https://parkinsonspathways.com/learn/what-do-clinical-trial-phases-mean.md
- What Do Clinical Trial Statuses Mean? — HTML: https://parkinsonspathways.com/learn/what-do-clinical-trial-statuses-mean — Markdown: https://parkinsonspathways.com/learn/what-do-clinical-trial-statuses-mean.md
- How Long Does a Parkinson's Clinical Trial Last? — HTML: https://parkinsonspathways.com/learn/how-long-does-a-parkinsons-clinical-trial-last — Markdown: https://parkinsonspathways.com/learn/how-long-does-a-parkinsons-clinical-trial-last.md
- How to Talk to Your Neurologist About Clinical Trials — HTML: https://parkinsonspathways.com/learn/how-to-talk-to-your-neurologist-about-clinical-trials — Markdown: https://parkinsonspathways.com/learn/how-to-talk-to-your-neurologist-about-clinical-trials.md
- Just Diagnosed with Parkinson's? Where to Start with Clinical Trials — HTML: https://parkinsonspathways.com/learn/just-diagnosed-with-parkinsons-clinical-trials — Markdown: https://parkinsonspathways.com/learn/just-diagnosed-with-parkinsons-clinical-trials.md
- Stem Cell Therapy for Parkinson's: What You Should Actually Know — HTML: https://parkinsonspathways.com/learn/stem-cell-therapy-for-parkinsons — Markdown: https://parkinsonspathways.com/learn/stem-cell-therapy-for-parkinsons.md
- Will My Family Member Get a Placebo? — HTML: https://parkinsonspathways.com/learn/will-my-family-member-get-a-placebo — Markdown: https://parkinsonspathways.com/learn/will-my-family-member-get-a-placebo.md
- How Close Is a Cure for Parkinson's Disease? — HTML: https://parkinsonspathways.com/learn/how-close-is-a-cure-for-parkinsons — Markdown: https://parkinsonspathways.com/learn/how-close-is-a-cure-for-parkinsons.md
- Parkinson's and Dementia: Clinical Trials Families Should Know — HTML: https://parkinsonspathways.com/learn/parkinsons-and-dementia-clinical-trials — Markdown: https://parkinsonspathways.com/learn/parkinsons-and-dementia-clinical-trials.md
- What Is Levodopa and How Does It Work? — HTML: https://parkinsonspathways.com/learn/what-is-levodopa-and-how-does-it-work — Markdown: https://parkinsonspathways.com/learn/what-is-levodopa-and-how-does-it-work.md
- What to Expect in the First Year After Diagnosis — HTML: https://parkinsonspathways.com/learn/what-to-expect-first-year-after-parkinsons-diagnosis — Markdown: https://parkinsonspathways.com/learn/what-to-expect-first-year-after-parkinsons-diagnosis.md
- Diet and Parkinson's Risk: What the Research Says — HTML: https://parkinsonspathways.com/learn/diet-and-parkinsons-risk — Markdown: https://parkinsonspathways.com/learn/diet-and-parkinsons-risk.md
- ClinicalTrials.gov vs Parkinson's Pathways — HTML: https://parkinsonspathways.com/learn/clinicaltrials-gov-vs-parkinsons-pathways — Markdown: https://parkinsonspathways.com/learn/clinicaltrials-gov-vs-parkinsons-pathways.md
- Interventional vs Observational Parkinson's Trials — HTML: https://parkinsonspathways.com/learn/interventional-vs-observational-parkinsons-trials — Markdown: https://parkinsonspathways.com/learn/interventional-vs-observational-parkinsons-trials.md
- Phase 1 vs Phase 2 vs Phase 3 Trials — HTML: https://parkinsonspathways.com/learn/phase-1-vs-phase-2-vs-phase-3-trials — Markdown: https://parkinsonspathways.com/learn/phase-1-vs-phase-2-vs-phase-3-trials.md
- Disease-Modifying vs Symptomatic Parkinson's Trials — HTML: https://parkinsonspathways.com/learn/disease-modifying-vs-symptomatic-parkinsons-trials — Markdown: https://parkinsonspathways.com/learn/disease-modifying-vs-symptomatic-parkinsons-trials.md
- Industry-Sponsored vs Academic Parkinson's Trials — HTML: https://parkinsonspathways.com/learn/industry-sponsored-vs-academic-parkinsons-trials — Markdown: https://parkinsonspathways.com/learn/industry-sponsored-vs-academic-parkinsons-trials.md
- Clinical Trial vs Standard of Care — HTML: https://parkinsonspathways.com/learn/clinical-trial-vs-standard-of-care-parkinsons — Markdown: https://parkinsonspathways.com/learn/clinical-trial-vs-standard-of-care-parkinsons.md
- dbs-vs-duopa-vs-focused-ultrasound-parkinsons — HTML: https://parkinsonspathways.com/learn/dbs-vs-duopa-vs-focused-ultrasound-parkinsons — Markdown: https://parkinsonspathways.com/learn/dbs-vs-duopa-vs-focused-ultrasound-parkinsons.md
- parkinsons-vs-lewy-body-dementia-vs-psp-vs-msa — HTML: https://parkinsonspathways.com/learn/parkinsons-vs-lewy-body-dementia-vs-psp-vs-msa — Markdown: https://parkinsonspathways.com/learn/parkinsons-vs-lewy-body-dementia-vs-psp-vs-msa.md
- parkinsons-vs-essential-tremor — HTML: https://parkinsonspathways.com/learn/parkinsons-vs-essential-tremor — Markdown: https://parkinsonspathways.com/learn/parkinsons-vs-essential-tremor.md
- levodopa-vs-dopamine-agonists — HTML: https://parkinsonspathways.com/learn/levodopa-vs-dopamine-agonists — Markdown: https://parkinsonspathways.com/learn/levodopa-vs-dopamine-agonists.md
- carbidopa-levodopa-formulations-compared — HTML: https://parkinsonspathways.com/learn/carbidopa-levodopa-formulations-compared — Markdown: https://parkinsonspathways.com/learn/carbidopa-levodopa-formulations-compared.md
- glp1-drugs-parkinsons-research — HTML: https://parkinsonspathways.com/learn/glp1-drugs-parkinsons-research — Markdown: https://parkinsonspathways.com/learn/glp1-drugs-parkinsons-research.md

## PD Curated — Trial Pages (Markdown twins)

Every recruiting Parkinson's trial has a Markdown twin at `/trial/{nctId}.md` containing the AI summary, five-word goal, plain-language eligibility, geocoded sites, contact info, and recent site changes (last 30 days). The full set is in the sitemap; below are the 50 most recently updated for quick discovery.

- New medication reduces movement stiffness (EUCT-2024-517310-15-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-517310-15-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-517310-15-00.md
- Measure abnormal brain protein accurately (EUCT-2023-508718-40-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-508718-40-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-508718-40-00.md
- Improve movement and reduce stiffness (EUCT-2025-522653-19-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-522653-19-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-522653-19-00.md
- New medication reduces movement stiffness (EUCT-2024-517413-33-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-517413-33-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-517413-33-00.md
- Check medication impact on immunity (EUCT-2024-514530-21-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-514530-21-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-514530-21-00.md
- Testing new Parkinson treatment approach (EUCT-2025-522441-21-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-522441-21-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-522441-21-00.md
- Ensure medication patch stays attached (EUCT-2025-521172-64-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-521172-64-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-521172-64-00.md
- New medication reduces tremor severity (EUCT-2024-516888-84-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-516888-84-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-516888-84-00.md
- New medication slows disease progression (EUCT-2024-520069-30-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-520069-30-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-520069-30-00.md
- Testing new Parkinson treatment approach (EUCT-2024-510959-35-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-510959-35-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-510959-35-00.md
- Slow brain cell loss early (EUCT-2024-519088-16-01) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-519088-16-01 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-519088-16-01.md
- New drug slows Parkinson progression (EUCT-2023-504278-39-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-504278-39-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-504278-39-00.md
- Stem cell transplant reduces tremor (EUCT-2024-511237-35-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-511237-35-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-511237-35-00.md
- New medication safety early Parkinson (EUCT-2022-502207-30-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2022-502207-30-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2022-502207-30-00.md
- Reduce medication wearing off episodes (EUCT-2025-521772-57-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-521772-57-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-521772-57-00.md
- Ease end of life anxiety (EUCT-2023-510488-36-01) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-510488-36-01 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-510488-36-01.md
- Brain protein imaging guides care (EUCT-2023-503705-10-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-503705-10-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-503705-10-00.md
- Relate brain serotonin to pain (EUCT-2022-501123-24-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2022-501123-24-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2022-501123-24-00.md
- New drug targets movement stiffness (EUCT-2024-519587-40-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-519587-40-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-519587-40-00.md
- Testing new Parkinson treatment approach (EUCT-2022-500292-31-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2022-500292-31-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2022-500292-31-00.md
- New medication safety for Parkinson (EUCT-2024-511222-30-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-511222-30-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-511222-30-00.md
- Measure brain clearance pump function (EUCT-2024-518865-85-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-518865-85-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-518865-85-00.md
- Evaluate safety of new medication (EUCT-2025-523872-22-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-523872-22-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-523872-22-00.md
- Detect early brain serotonin changes (EUCT-2024-516610-38-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-516610-38-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-516610-38-00.md
- Detect harmful brain protein buildup (EUCT-2023-506965-72-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-506965-72-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-506965-72-00.md
- Determine tolerated doses for motivation (EUCT-2025-523612-37-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-523612-37-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-523612-37-00.md
- New medication matches current medication (EUCT-2026-525448-14-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2026-525448-14-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2026-525448-14-00.md
- Testing new Parkinson treatment approach (EUCT-2025-522261-30-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-522261-30-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-522261-30-00.md
- Slow Parkinson progression with medication (EUCT-2023-504412-14-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-504412-14-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-504412-14-00.md
- New drug slows Parkinson progression (EUCT-2025-521357-17-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-521357-17-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-521357-17-00.md
- Slow brain cell loss early (EUCT-2023-507132-21-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-507132-21-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-507132-21-00.md
- Reduce hand tremor during activities (EUCT-2024-515177-94-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-515177-94-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-515177-94-00.md
- New medication reduces movement stiffness (EUCT-2025-521819-39-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-521819-39-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-521819-39-00.md
- Reduce medication wearing off episodes (EUCT-2024-513548-27-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-513548-27-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-513548-27-00.md
- Guide dosing for new medication (EUCT-2023-507959-29-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-507959-29-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-507959-29-00.md
- New medication slows early progression (EUCT-2025-524674-42-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-524674-42-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-524674-42-00.md
- Assess medication safety for Parkinson (EUCT-2023-507910-28-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-507910-28-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-507910-28-00.md
- Test safety of new medication (EUCT-2024-511110-21-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-511110-21-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-511110-21-00.md
- Slow brain cell loss early (EUCT-2024-514976-41-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-514976-41-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-514976-41-00.md
- Testing new Parkinson treatment approach (EUCT-2023-509158-68-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-509158-68-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-509158-68-00.md
- Testing new Parkinson treatment approach (EUCT-2024-519835-41-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-519835-41-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-519835-41-00.md
- New medication reduces tremor severity (EUCT-2023-503203-29-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-503203-29-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-503203-29-00.md
- Make Parkinson medicine work longer (EUCT-2024-510629-24-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-510629-24-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-510629-24-00.md
- Continuous medication reduces motor fluctuations (EUCT-2024-517566-42-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-517566-42-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-517566-42-00.md
- New medication slows early Parkinson (EUCT-2022-502207-30-01) — HTML: https://parkinsonspathways.com/trial/EUCT-2022-502207-30-01 — Markdown: https://parkinsonspathways.com/trial/EUCT-2022-502207-30-01.md
- Continuous skin infusion steadies movement (EUCT-2024-511940-20-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2024-511940-20-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2024-511940-20-00.md
- New drug reduces movement stiffness (EUCT-2023-507785-12-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-507785-12-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-507785-12-00.md
- Testing new Parkinson treatment approach (EUCT-2025-520754-11-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2025-520754-11-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2025-520754-11-00.md
- New medication slows Parkinson progression (EUCT-2022-500424-30-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2022-500424-30-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2022-500424-30-00.md
- New medication slows Parkinson progression (EUCT-2023-505645-12-00) — HTML: https://parkinsonspathways.com/trial/EUCT-2023-505645-12-00 — Markdown: https://parkinsonspathways.com/trial/EUCT-2023-505645-12-00.md

## Universal Raw Mirror (any condition)

A separate, condition-agnostic mirror of ClinicalTrials.gov. **Raw data only — no AI summaries, no PD-specific filtering, no editorial enrichment.** Use this when you want source-of-truth data with field-level change tracking.

- URL pattern: https://parkinsonspathways.com/agent/trials/{nctId}.md
- Authoritative source: https://clinicaltrials.gov/study/{nctId}

## Agent API

A programmatic API namespace for agents and downstream services is in the works. Entry point will live at `https://parkinsonspathways.com/api/agent/` and will expose change feeds, matching, and replay endpoints. Until that ships, retrieve content via the Markdown URLs above.

## Machine-Readable Resources

- [Sitemap](https://parkinsonspathways.com/sitemap.xml) — includes Learn and PD-trial Markdown twins
- [Sitemap Index](https://parkinsonspathways.com/sitemap-index.xml) — references the main sitemap plus paginated child sitemaps for every universal-mirror Markdown URL
- [Full LLM Context](https://parkinsonspathways.com/llms-full.txt)